180 Life Sciences transitions to ETHZilla, focusing on an ether-based treasury strategy with significant backing from institutional investors, aiming for higher yields through innovative financial practices.
180 Life Sciences is rebranding as ETHZilla after securing $425 million in private funding to pivot toward an ether-focused treasury strategy. The investment is backed by sixty institutional and crypto-native investors, including Polychain Capital and Electric Capital. The company plans to accumulate ether as its core treasury asset and generate higher yields through an on-chain yield generation program. Electric Capital will act as ETHZilla’s external asset manager, and a DeFi Council will be established to guide the company's strategies.